SOSV

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

Beeflow S.A. is a company that specializes in professional pollination services, focusing on the enhancement of bee health and efficiency. Founded in 2016 and headquartered in Buenos Aires, Argentina, Beeflow employs scientific techniques and organic compounds to improve the immune systems of bees, enabling them to effectively pollinate specific crops. The company has demonstrated significant success in increasing crop yields, with reported improvements ranging from 20% to 90% in various fruits such as blueberries, almonds, raspberries, and kiwifruit. Since its inception, Beeflow has expanded its operations to the United States and continues to grow its presence, particularly in Ventura County, California. The company's efforts aim to address the challenges of declining bee populations while supporting agricultural productivity.

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

Moirai Biodesign develops RNA-based therapies and diagnostics for cancer. The company develops non-invasive tests for in-vitro and in-situ diagnosis of AML using the patients blood; in-vivo diagnosis systems for surgical assistance and patient monitoring; and therapeutical drugs for treating cancer. Its pipeline includes RNA biomarker discovery, plug and play bio device design, and platform delivery system. The company was founded in 2016 and is based in Ireland.

Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics'​ technology leverages massive gains in print speed and resolution to break the microvasculature barrier.

Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels. Capra Biosciences was founded in 2020 and is headquartered in Alexandria, VA.

Alternative Plants is a biotech start-up that establishes plant stem cell cultures for effective, consistent and sustainable production of cosmetic active ingredients. Our focus is on medicinal plants that are difficult to grow, are rare or even endangered, so our plant stem cell culture technology is the only way to access the valuable substances that they produce. Our current focus is on cosmetic active ingredients market. Our clients are cosmetic manufacturers that use our plant stem cell derived active substances as key active ingredients in their products. In the same time we clearly see that with our technology we can later expand to other markets as functional foods, medical devices and pharma as well.

Unicorn Biotechnologies is developing a fully automated manufacturing platform to enable cellular agriculture producers to seamlessly scale products from the lab bench to supermarket shelves. Our full stack platform combines hardware, software and analytics to completely automate cellular agriculture manufacturing, reducing costs and increasing product quality. By providing a clear path to scale cellular agriculture from grams to tons, we will improve human and planetary health and drive the transition to animal free agriculture.

OzoneBio is a cleantech company that focuses on lignocellulosic waste-derived bio-plastics production. In its workflow, they utilize the unique technology of dead cell fermentation («Zombie cells») that allows them to convert challenging/toxic feedstocks into high-value products and avoid significant expenses and complications related to live-cell fermentation. OzoneBio was founded in 2021 and is headquartered in Toronto, Canada.

Innatrix is an agricultural biotechnology company developing novel biological and chemical products based on patented protein evolution technology, to control untreatable crop diseases, pests, and weeds.

Innatrix is an agricultural biotechnology company developing novel biological and chemical products based on patented protein evolution technology, to control untreatable crop diseases, pests, and weeds.

Stämm Biotech, founded in 2014 and based in San Francisco, California, specializes in innovative biomanufacturing solutions for the life sciences sector. The company has developed a novel bioproduction system that integrates microfluidics, electroporation, and robotics to address the challenges of scaling in the biotech industry. Stämm's flagship product, the Bioprocessor, is an all-in-one, plug-and-play desktop unit that significantly enhances productivity, being at least 70 times more efficient than conventional bioreactors. Additionally, Stämm offers a suite of products including an automated continuous batch system for microbial growth, tools for tracking biological variations, and systems for monitoring microorganisms to convert data into actionable insights. This technological advancement positions Stämm to unlock a substantial market opportunity in biomanufacturing over the next decade.

The Quantumcyte team is a highly talented group of biology and high tech commercialization experts with experience in academic, biotech, diagnostics, medical device and high tech organizations including Stanford, Intel, Thermo Fisher, Johnson and Johnson, Genentech and others. They are driven to ensure scalability and manufacturability of their products. To meet the basic research needs they have forged very close relationships and collaborations with experts in the field of cancer and genomic sequencing.

NovoNutrients is focused on converting industrial waste carbon dioxide emissions into high-value protein ingredients for food and animal feed. The company has developed a fermentation platform that utilizes proprietary microbes and advanced gas fermentation systems to transform CO2, along with hydrogen and oxygen, into complete and safe single-cell protein. This innovative approach not only provides sustainable protein sources to support a growing population but also plays a role in combating climate change through carbon capture and utilization. By addressing both food security and environmental sustainability, NovoNutrients aims to meet the increasing demand for alternative protein solutions.

Ceragen is a biotechnology company based in Kitchener, Ontario, focused on enhancing agricultural productivity through plant microbiome engineering. The company specializes in precision microbiome engineering, offering inoculant products specifically designed for controlled environment agriculture. These products aim to provide farmers with natural solutions that enhance crop yields, allowing them to grow more food in smaller spaces. By improving plants' resilience to environmental stressors, Ceragen's innovations support sustainable farming practices and contribute to the efficient use of land resources, addressing the growing need to feed the global population.

Inso Biosciences is an early-stage biotechnology company based in Ithaca, New York, affiliated with Cornell University. The company focuses on developing innovative platform technology for biological sample processing, specifically designed for genomic analysis, including DNA sequencing. Utilizing advanced microfluidic technology, Inso Biosciences aims to revolutionize sample processing by efficiently separating and isolating cellular components. This technology enables healthcare and biotechnology companies to enhance their biological sample preparation capabilities, facilitating more effective research and analysis in the field of genomics.

Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels. Capra Biosciences was founded in 2020 and is headquartered in Alexandria, VA.

100% naturally bio-based material made from food waste

VemiCo is a biotechnology company.

ZymoChem, Inc. develops microbes and bioprocesses that enable production of chemicals from renewable sources, such as sugars. The company was founded in 2013 and is based in Emeryville, California.

Carverr, Inc. is a biotechnology company based in Brooklyn, New York, founded in 2018. The company specializes in developing technology to enhance product authenticity and safety through innovative solutions. Its flagship offering, ABIOGEN, utilizes programmable molecules that can be integrated into various forms, such as liquids and solids, to authenticate organic and non-organic food ingredients, agrochemicals, and consumer goods. Additionally, Carverr provides CERBERUS, a solution that transforms labels into authentication tools designed to combat counterfeiting and safeguard product quality and brand identity. The CERBERUS labels incorporate multiple security layers that can be verified by various stakeholders, ensuring the authenticity of the product. Through its advancements, Carverr aims to improve supply chain integrity and support sustainable practices within the agricultural and food sectors.

Gaia Laboratories revolutionizes cell production, creating powerful solutions for the defining challenges of time. The founding principles behind Gaia Laboratories are to combat climate change, enable space-food, and make cell therapy accessible to everyone.

Ardra is a startup based on technology developed at the University of Toronto. Their technology uses model-guided metabolic engineering and synthetic biology to develop biocatalysts for the production of specialty chemicals from renewable resources. Their current target is the cosmetics industry, which uses $2.6 billion worth of petroleum chemicals in a variety of products.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

BioSapien is a biotech startup that focuses on developing a 3D printed drug delivery platform to provide FDA approved drugs. The startup's device allows chemotherapy to be delivered intravenously through a controlled drug release and enables physicians to reduce harmful side-effects and dramatically reduce costs. BioSapien was established in 2018 and is based in New York.

DropGenie is a biotechnology company founded in 2018 and based in Montreal, Canada. The company focuses on developing connected hardware that automates gene editing processes, thereby enhancing the efficiency of genetic engineering. Its platform streamlines liquid handling and experimental conditions, which helps scientists reduce costs while improving the standardization and reproducibility of their work. By generating standardized and compatible scientific information, DropGenie aims to accelerate the pace of discovery in the field of genetics, making advancements in gene editing more accessible to researchers.

Indee Labs is developing hardware for gene delivery. Our hardware is uniquely positioned for the efficient development and scalable manufacture of gene-modified cell therapies such as chimeric antigen receptor T cells. The technology is being developed with the help of the Australian National Fabrication Facility. We are alumni of NSW Health, IndieBio, Y Combinator and MBC Biolabs (née QB3@953). We are opening up an office in Sydney and have lab space at Bonneville Labs in Berkeley.

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

ZymoChem, Inc. develops microbes and bioprocesses that enable production of chemicals from renewable sources, such as sugars. The company was founded in 2013 and is based in Emeryville, California.

Karma Biotechnologies, Inc. develops therapies for autoimmune diseases. It offers Xavines, a therapeutic to treat autoimmunity, allergies, and food sensitivities. Karma Biotechnologies, Inc. was incorporated in 2019 and is based in Los Angeles, California.

Inso Biosciences is an early-stage biotechnology company based in Ithaca, New York, affiliated with Cornell University. The company focuses on developing innovative platform technology for biological sample processing, specifically designed for genomic analysis, including DNA sequencing. Utilizing advanced microfluidic technology, Inso Biosciences aims to revolutionize sample processing by efficiently separating and isolating cellular components. This technology enables healthcare and biotechnology companies to enhance their biological sample preparation capabilities, facilitating more effective research and analysis in the field of genomics.

Inso Biosciences is an early-stage biotechnology company based in Ithaca, New York, affiliated with Cornell University. The company focuses on developing innovative platform technology for biological sample processing, specifically designed for genomic analysis, including DNA sequencing. Utilizing advanced microfluidic technology, Inso Biosciences aims to revolutionize sample processing by efficiently separating and isolating cellular components. This technology enables healthcare and biotechnology companies to enhance their biological sample preparation capabilities, facilitating more effective research and analysis in the field of genomics.

100% naturally bio-based material made from food waste

Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics'​ technology leverages massive gains in print speed and resolution to break the microvasculature barrier.

100% naturally bio-based material made from food waste

Beeflow S.A. is a company that specializes in professional pollination services, focusing on the enhancement of bee health and efficiency. Founded in 2016 and headquartered in Buenos Aires, Argentina, Beeflow employs scientific techniques and organic compounds to improve the immune systems of bees, enabling them to effectively pollinate specific crops. The company has demonstrated significant success in increasing crop yields, with reported improvements ranging from 20% to 90% in various fruits such as blueberries, almonds, raspberries, and kiwifruit. Since its inception, Beeflow has expanded its operations to the United States and continues to grow its presence, particularly in Ventura County, California. The company's efforts aim to address the challenges of declining bee populations while supporting agricultural productivity.

The Quantumcyte team is a highly talented group of biology and high tech commercialization experts with experience in academic, biotech, diagnostics, medical device and high tech organizations including Stanford, Intel, Thermo Fisher, Johnson and Johnson, Genentech and others. They are driven to ensure scalability and manufacturability of their products. To meet the basic research needs they have forged very close relationships and collaborations with experts in the field of cancer and genomic sequencing.

Diadem Biotherapeutics is a biotechnology company that focuses on creating bio-therapeutical materials produced using organic means. Diadem develops exosomes to treat chronic inflammatory and auto-immune conditions.

Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics'​ technology leverages massive gains in print speed and resolution to break the microvasculature barrier.

Ceragen is a biotechnology company based in Kitchener, Ontario, focused on enhancing agricultural productivity through plant microbiome engineering. The company specializes in precision microbiome engineering, offering inoculant products specifically designed for controlled environment agriculture. These products aim to provide farmers with natural solutions that enhance crop yields, allowing them to grow more food in smaller spaces. By improving plants' resilience to environmental stressors, Ceragen's innovations support sustainable farming practices and contribute to the efficient use of land resources, addressing the growing need to feed the global population.

Ceragen is a biotechnology company based in Kitchener, Ontario, focused on enhancing agricultural productivity through plant microbiome engineering. The company specializes in precision microbiome engineering, offering inoculant products specifically designed for controlled environment agriculture. These products aim to provide farmers with natural solutions that enhance crop yields, allowing them to grow more food in smaller spaces. By improving plants' resilience to environmental stressors, Ceragen's innovations support sustainable farming practices and contribute to the efficient use of land resources, addressing the growing need to feed the global population.

CyGenica uses a non-viral, non-toxic platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.

Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels. Capra Biosciences was founded in 2020 and is headquartered in Alexandria, VA.

BiomeSense is revolutionizing human microbiome research by developing novel technologies to enable investigators to collect, store, and analyze the daily microbiome profiles of clinical trial participants in a low-cost, scalable way. By enabling daily profiling, the platform allows investigators the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, dramatically increasing the research discovery potential.

Pregenerate, Inc. is a biotechnology company founded in 2019 and incorporated in Delaware. It specializes in developing scalable organ-on-a-chip models aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. By utilizing human cells in its innovative models, Pregenerate's technology not only enhances the efficiency of drug development but also improves success rates for bringing new medications to market. Furthermore, this approach allows for the stratification of patients into specific treatment subgroups, enabling healthcare providers to tailor therapies to individual needs. This focus on personalized medicine aims to significantly reduce the costs associated with traditional testing methods while advancing the understanding of treatment responses in patients with arthritis.

Stämm Biotech, founded in 2014 and based in San Francisco, California, specializes in innovative biomanufacturing solutions for the life sciences sector. The company has developed a novel bioproduction system that integrates microfluidics, electroporation, and robotics to address the challenges of scaling in the biotech industry. Stämm's flagship product, the Bioprocessor, is an all-in-one, plug-and-play desktop unit that significantly enhances productivity, being at least 70 times more efficient than conventional bioreactors. Additionally, Stämm offers a suite of products including an automated continuous batch system for microbial growth, tools for tracking biological variations, and systems for monitoring microorganisms to convert data into actionable insights. This technological advancement positions Stämm to unlock a substantial market opportunity in biomanufacturing over the next decade.

Protera Biosciences, Inc. specializes in the production of protein-based food ingredients, focusing on innovative solutions to enhance food quality and safety. Founded in 2015 and located in Sunnyvale, California, the company offers a range of products including Protera Guard, a clean label protein that extends shelf life and replaces chemical preservatives, and Protera Sense, a plant-based oil that improves food texture without the use of palm oil or trans fats. Additionally, Protera provides antioxidant proteins and foaming and emulsifying proteins suitable for various applications, such as bakery products, chocolate, ice cream, and plant-based meat alternatives. Utilizing a proprietary deep learning algorithm named MADI, Protera accelerates the design and development of high-value protein products and enzymes, allowing for rapid validation and collaboration with clients to scale production effectively while addressing ethical and environmental challenges in food manufacturing.

KOLIBRI is an early-stage deep-tech biotech start-up company that unlocks the potential of gene therapies and next-generation vaccines. It aims to make large-scale viral vector manufacturing cheaper and faster by combining cutting-edge techniques in chemical optimization and acoustics. The company was founded n 2020.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

PILI Inc. researches and manufactures bio-fabricated colors by using microorganisms. The company designs enzymes and fermentation biotechnologies to efficiently transform sugar into renewable and long-lasting colors. PILI Inc. produces renewable dyes and pigments. The company was founded in 2012 and is based in Paris, France.

OzoneBio is a cleantech company that focuses on lignocellulosic waste-derived bio-plastics production. In its workflow, they utilize the unique technology of dead cell fermentation («Zombie cells») that allows them to convert challenging/toxic feedstocks into high-value products and avoid significant expenses and complications related to live-cell fermentation. OzoneBio was founded in 2021 and is headquartered in Toronto, Canada.

Unicorn Biotechnologies is developing a fully automated manufacturing platform to enable cellular agriculture producers to seamlessly scale products from the lab bench to supermarket shelves. Our full stack platform combines hardware, software and analytics to completely automate cellular agriculture manufacturing, reducing costs and increasing product quality. By providing a clear path to scale cellular agriculture from grams to tons, we will improve human and planetary health and drive the transition to animal free agriculture.

OzoneBio is a cleantech company that focuses on lignocellulosic waste-derived bio-plastics production. In its workflow, they utilize the unique technology of dead cell fermentation («Zombie cells») that allows them to convert challenging/toxic feedstocks into high-value products and avoid significant expenses and complications related to live-cell fermentation. OzoneBio was founded in 2021 and is headquartered in Toronto, Canada.

Gaia Laboratories revolutionizes cell production, creating powerful solutions for the defining challenges of time. The founding principles behind Gaia Laboratories are to combat climate change, enable space-food, and make cell therapy accessible to everyone.

Carverr, Inc. is a biotechnology company based in Brooklyn, New York, founded in 2018. The company specializes in developing technology to enhance product authenticity and safety through innovative solutions. Its flagship offering, ABIOGEN, utilizes programmable molecules that can be integrated into various forms, such as liquids and solids, to authenticate organic and non-organic food ingredients, agrochemicals, and consumer goods. Additionally, Carverr provides CERBERUS, a solution that transforms labels into authentication tools designed to combat counterfeiting and safeguard product quality and brand identity. The CERBERUS labels incorporate multiple security layers that can be verified by various stakeholders, ensuring the authenticity of the product. Through its advancements, Carverr aims to improve supply chain integrity and support sustainable practices within the agricultural and food sectors.

Developing technology to fight mosquitoes with mosquitoes.

We are a platform of insect-based biotechnology integrating biology with engineering and molecular sciences to accelerate the building with biology. We are capitalizing on our experience with vertically farmed Black Soldier Fly to use the insect as a mini-biofactory reducing the capital and operational costs of conventional bioreactors.

We are a platform of insect-based biotechnology integrating biology with engineering and molecular sciences to accelerate the building with biology. We are capitalizing on our experience with vertically farmed Black Soldier Fly to use the insect as a mini-biofactory reducing the capital and operational costs of conventional bioreactors.

Gypsy Bay Genomics is combining scientific backgrounds in genomics and oncology with startup expertise to translate genetic discoveries into advances in personalized clinical care as it strives to develop technology that will decrease the rates of cervical cancer globally.

Gypsy Bay Genomics is combining scientific backgrounds in genomics and oncology with startup expertise to translate genetic discoveries into advances in personalized clinical care as it strives to develop technology that will decrease the rates of cervical cancer globally.

NovoNutrients is focused on converting industrial waste carbon dioxide emissions into high-value protein ingredients for food and animal feed. The company has developed a fermentation platform that utilizes proprietary microbes and advanced gas fermentation systems to transform CO2, along with hydrogen and oxygen, into complete and safe single-cell protein. This innovative approach not only provides sustainable protein sources to support a growing population but also plays a role in combating climate change through carbon capture and utilization. By addressing both food security and environmental sustainability, NovoNutrients aims to meet the increasing demand for alternative protein solutions.

Biomage specializes in single-cell analysis transforming the life sciences. Our goal is to apply innovative computational methods to extract valuable insight from biological data, fueling cutting-edge research across biological disciplines. Our flagship product, the Biomage Single Cell Platform empowers researchers to take ownership of their single cell data analysis, generating deep biological insight in just a few clicks.

Chinova Bioworks Inc. develops personalized natural antimicrobials for the beverage industry. Its natural antimicrobials protect fresh juices from spoilage and enhance the shelf life of these products. The company was founded in 2016 and is based in Fredericton, Canada.

Transforming the performance of protein powders through our patent-pending Ingredient Optimization process to increase sustainability and improve health outcomes.

BiomeSense is revolutionizing human microbiome research by developing novel technologies to enable investigators to collect, store, and analyze the daily microbiome profiles of clinical trial participants in a low-cost, scalable way. By enabling daily profiling, the platform allows investigators the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, dramatically increasing the research discovery potential.

Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels. Capra Biosciences was founded in 2020 and is headquartered in Alexandria, VA.

Capra Biosciences is a biotechnology company harnessing biology for efficient and low-carbon production of everyday chemicals. It develops bioreactor technology designed to make the production of chemical products more efficient. The company developed a biofilm bioreactor which has the potential to significantly reduce the downstream processing requirements and costs inherent in the bio-manufacturing of products such as fuels. Capra Biosciences was founded in 2020 and is headquartered in Alexandria, VA.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, established in 2018. The company specializes in developing proprietary protein engineering and expression platforms to create innovative plant-inspired proteins, such as brazzein, for applications in the food and beverage industries. Additionally, Magellan Life Sciences offers the XSeed platform, which leverages synthetic biology to advance the development of novel proteins aimed at enhancing the food, health, and nutrition sectors.

Bucha Bio creates a novel biomaterial grown from infinitely renewable bacterial-nanocellulose. Strands of natural fibers interlock to form a high-performance textile with a luxuriously soft handfeel. Produced in weeks rather than months or years, use it in premium applications instead of animal leather, polyurethane, latex, vinyl, and so much more. Creating a reliable material is our goal, adding plastics and petrochemicals like PU polyurethane would make it easy, but we’ve never taken the easy way out. Committed to sustainability, Bucha Bio’s team is dedicated to creating a completely biodegradable textile that enables the next generation of designers to create products for a more sustainable future. Our biomaterial is water-resistant, scratch-resistant, sunlight-resistant, flame-resistant, and so many more reasons to test it out in your next product.

Bucha Bio creates a novel biomaterial grown from infinitely renewable bacterial-nanocellulose. Strands of natural fibers interlock to form a high-performance textile with a luxuriously soft handfeel. Produced in weeks rather than months or years, use it in premium applications instead of animal leather, polyurethane, latex, vinyl, and so much more. Creating a reliable material is our goal, adding plastics and petrochemicals like PU polyurethane would make it easy, but we’ve never taken the easy way out. Committed to sustainability, Bucha Bio’s team is dedicated to creating a completely biodegradable textile that enables the next generation of designers to create products for a more sustainable future. Our biomaterial is water-resistant, scratch-resistant, sunlight-resistant, flame-resistant, and so many more reasons to test it out in your next product.

Moirai Biodesign develops RNA-based therapies and diagnostics for cancer. The company develops non-invasive tests for in-vitro and in-situ diagnosis of AML using the patients blood; in-vivo diagnosis systems for surgical assistance and patient monitoring; and therapeutical drugs for treating cancer. Its pipeline includes RNA biomarker discovery, plug and play bio device design, and platform delivery system. The company was founded in 2016 and is based in Ireland.

Pregenerate, Inc. is a biotechnology company founded in 2019 and incorporated in Delaware. It specializes in developing scalable organ-on-a-chip models aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. By utilizing human cells in its innovative models, Pregenerate's technology not only enhances the efficiency of drug development but also improves success rates for bringing new medications to market. Furthermore, this approach allows for the stratification of patients into specific treatment subgroups, enabling healthcare providers to tailor therapies to individual needs. This focus on personalized medicine aims to significantly reduce the costs associated with traditional testing methods while advancing the understanding of treatment responses in patients with arthritis.

BioAesthetics was founded in 2015 as a Tulane University spin-out with the mission to improve reconstruction options for breast cancer patients after they undergo mastectomies. The BioAesthetics’ initial product is a tissue-engineered nipple-areolar complex (NAC). This product will be provided to plastic and reconstructive surgeons as an off-the-shelf ready, acellular, NAC graft. During the breast reconstruction phase, after a mastectomy, the surgeon would engraft the NAC graft in position onto the patient’s reconstructed breast. The patient’s body would then use this NAC graft as a building frame to regenerate their own NAC. This patent-pending product is currently in the pre-clinical phase.

renegade.bio is a biotechnology startup dedicated to developing and deploying high throughput diagnostics for the detection of novel infectious diseases.

AsimicA focuses on developing novel technologies for improved production in Microbial Biosynthetic Factories. Their technologies have the potential for a multi-fold increase in yields of biosynthetic processes. Since relatively low yields of target products, made through the biosynthesis is the major limitation of biotechnology, our innovative approaches for production may revolutionize the industry. AsimicA was launched in November 2018, by Nikolai Mushnikov and Grant Bowman.

Gaia Laboratories revolutionizes cell production, creating powerful solutions for the defining challenges of time. The founding principles behind Gaia Laboratories are to combat climate change, enable space-food, and make cell therapy accessible to everyone.

Cybele Microbiome offers a proprietary platform creates natural products in 16X less time than conventional manufacturing. The company was founded by Nicole Scott in 2017 and it is based in San Diego, California.

Cybele Microbiome offers a proprietary platform creates natural products in 16X less time than conventional manufacturing. The company was founded by Nicole Scott in 2017 and it is based in San Diego, California.

Protera Biosciences, Inc. specializes in the production of protein-based food ingredients, focusing on innovative solutions to enhance food quality and safety. Founded in 2015 and located in Sunnyvale, California, the company offers a range of products including Protera Guard, a clean label protein that extends shelf life and replaces chemical preservatives, and Protera Sense, a plant-based oil that improves food texture without the use of palm oil or trans fats. Additionally, Protera provides antioxidant proteins and foaming and emulsifying proteins suitable for various applications, such as bakery products, chocolate, ice cream, and plant-based meat alternatives. Utilizing a proprietary deep learning algorithm named MADI, Protera accelerates the design and development of high-value protein products and enzymes, allowing for rapid validation and collaboration with clients to scale production effectively while addressing ethical and environmental challenges in food manufacturing.

Gaia Laboratories revolutionizes cell production, creating powerful solutions for the defining challenges of time. The founding principles behind Gaia Laboratories are to combat climate change, enable space-food, and make cell therapy accessible to everyone.

Gaia Laboratories revolutionizes cell production, creating powerful solutions for the defining challenges of time. The founding principles behind Gaia Laboratories are to combat climate change, enable space-food, and make cell therapy accessible to everyone.

renegade.bio is a biotechnology startup dedicated to developing and deploying high throughput diagnostics for the detection of novel infectious diseases.

DropGenie is a biotechnology company founded in 2018 and based in Montreal, Canada. The company focuses on developing connected hardware that automates gene editing processes, thereby enhancing the efficiency of genetic engineering. Its platform streamlines liquid handling and experimental conditions, which helps scientists reduce costs while improving the standardization and reproducibility of their work. By generating standardized and compatible scientific information, DropGenie aims to accelerate the pace of discovery in the field of genetics, making advancements in gene editing more accessible to researchers.

Biomage specializes in single-cell analysis transforming the life sciences. Our goal is to apply innovative computational methods to extract valuable insight from biological data, fueling cutting-edge research across biological disciplines. Our flagship product, the Biomage Single Cell Platform empowers researchers to take ownership of their single cell data analysis, generating deep biological insight in just a few clicks.

Developing technology to fight mosquitoes with mosquitoes.

renegade.bio is a biotechnology startup dedicated to developing and deploying high throughput diagnostics for the detection of novel infectious diseases.

Developing hardware for manufacturing next-generation medicines.

Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics'​ technology leverages massive gains in print speed and resolution to break the microvasculature barrier.

Developing hardware for manufacturing next-generation medicines.

Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.

Briefcase Biotec develops KiloBaser, a Nespresso machine of DNA synthesis - enabling cutting edge research without detours. KiloBaser is a device for printing short synthetic DNA sequences. It enables individual scientists to easily produce the DNA they need on their desktops, while speeding up production of the basics for all genetic engineering and synthetic biology research and development. Headquartered in Graz, Steiermark, KiloBaser was founded in 2013 by Martin Jost and Alexander Murer.

renegade.bio is a biotechnology startup dedicated to developing and deploying high throughput diagnostics for the detection of novel infectious diseases.

Chi Botanic is a plant cell company that provides synthetic biology pipeline to leverage the power of the plant cell. Chi Botanic's technology called plant cell agriculture, creates end products, in bioreactors, without any of the waste such as aloe, natural rubber, and citrus oils, to turn plants into plant cells to make products, allowing users to change the way plant cells are grown. Chi Botanic was founded in 2017.

Synthace Limited is a company that develops software and processes aimed at enhancing productivity in biosciences across various industries, including health, pharmaceuticals, food, energy, agri-science, and manufacturing. Central to its offerings is Antha, a cloud-based platform designed to automate and improve biological processes. Antha allows users to visually design, execute, and analyze biological workflows, linking lab equipment, protocols, and processes to enable repeatable and efficient development. Founded in 2011 and headquartered in London, with an additional location in Cambridge, Massachusetts, Synthace also maintains a strategic partnership with Microsoft to further its mission of increasing bioscience productivity and facilitating better engineering of biological systems.

BioSapien is a biotech startup that focuses on developing a 3D printed drug delivery platform to provide FDA approved drugs. The startup's device allows chemotherapy to be delivered intravenously through a controlled drug release and enables physicians to reduce harmful side-effects and dramatically reduce costs. BioSapien was established in 2018 and is based in New York.

Moirai Biodesign develops RNA-based therapies and diagnostics for cancer. The company develops non-invasive tests for in-vitro and in-situ diagnosis of AML using the patients blood; in-vivo diagnosis systems for surgical assistance and patient monitoring; and therapeutical drugs for treating cancer. Its pipeline includes RNA biomarker discovery, plug and play bio device design, and platform delivery system. The company was founded in 2016 and is based in Ireland.

Carverr, Inc. is a biotechnology company based in Brooklyn, New York, founded in 2018. The company specializes in developing technology to enhance product authenticity and safety through innovative solutions. Its flagship offering, ABIOGEN, utilizes programmable molecules that can be integrated into various forms, such as liquids and solids, to authenticate organic and non-organic food ingredients, agrochemicals, and consumer goods. Additionally, Carverr provides CERBERUS, a solution that transforms labels into authentication tools designed to combat counterfeiting and safeguard product quality and brand identity. The CERBERUS labels incorporate multiple security layers that can be verified by various stakeholders, ensuring the authenticity of the product. Through its advancements, Carverr aims to improve supply chain integrity and support sustainable practices within the agricultural and food sectors.

Chi Botanic is a plant cell company that provides synthetic biology pipeline to leverage the power of the plant cell. Chi Botanic's technology called plant cell agriculture, creates end products, in bioreactors, without any of the waste such as aloe, natural rubber, and citrus oils, to turn plants into plant cells to make products, allowing users to change the way plant cells are grown. Chi Botanic was founded in 2017.

Blue Planet Ecosystems is a team of engineers, biologists and computer scientists that have set out to revolutionize the way humanity is growing food in the face of climate change and continuing urbanization. Using their CLPPR, they want to produce high-quality, pollutant-free and pharmacologically unimpaired fish. In order to achieve this, they use selected strains of green microalgae and, by the help of their self-designed algorithms, the advantages of Closed Loop Systems and sunlight, turn them into fish.

MicroSynbiotiX Limited specializes in developing oral vaccines for the aquaculture sector, aiming to reduce the reliance on antibiotics in farmed fish. Founded in 2016 and based in Cork City, Ireland, the company utilizes advancements in algal genomics and molecular biology to engineer microalgae that can produce therapeutic proteins and vaccines at a lower cost. By employing microalgae as an oral delivery system, MicroSynbiotiX significantly lowers both labor and post-processing expenses, resulting in more affordable and accessible vaccines. This innovative approach not only helps to decrease fish mortality rates and combat bacterial and viral diseases in aquaculture but also contributes to enhanced global food security.